Cargando…
Differential activity and expression of human 5β-reductase (AKR1D1) splice variants
Steroid hormones, including glucocorticoids and androgens, exert a wide variety of effects in the body across almost all tissues. The steroid A-ring 5β-reductase (AKR1D1) is expressed in human liver and testes, and three splice variants have been identified (AKR1D1-001, AKR1D1-002, AKR1D1-006). Amon...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7965358/ https://www.ncbi.nlm.nih.gov/pubmed/33502336 http://dx.doi.org/10.1530/JME-20-0160 |
_version_ | 1783665644568313856 |
---|---|
author | Appanna, Nathan Gibson, Hylton Gangitano, Elena Dempster, Niall J Morris, Karen George, Sherly Arvaniti, Anastasia Gathercole, Laura L Keevil, Brian Penning, Trevor M Storbeck, Karl-Heinz Tomlinson, Jeremy W Nikolaou, Nikolaos |
author_facet | Appanna, Nathan Gibson, Hylton Gangitano, Elena Dempster, Niall J Morris, Karen George, Sherly Arvaniti, Anastasia Gathercole, Laura L Keevil, Brian Penning, Trevor M Storbeck, Karl-Heinz Tomlinson, Jeremy W Nikolaou, Nikolaos |
author_sort | Appanna, Nathan |
collection | PubMed |
description | Steroid hormones, including glucocorticoids and androgens, exert a wide variety of effects in the body across almost all tissues. The steroid A-ring 5β-reductase (AKR1D1) is expressed in human liver and testes, and three splice variants have been identified (AKR1D1-001, AKR1D1-002, AKR1D1-006). Amongst these, AKR1D1-002 is the best described; it modulates steroid hormone availability and catalyses an important step in bile acid biosynthesis. However, specific activity and expression of AKR1D1-001 and AKR1D1-006 are unknown. Expression of AKR1D1 variants were measured in human liver biopsies and hepatoma cell lines by qPCR. Their three-dimensional (3D) structures were predicted using in silico approaches. AKR1D1 variants were overexpressed in HEK293 cells, and successful overexpression confirmed by qPCR and Western blotting. Cells were treated with either cortisol, dexamethasone, prednisolone, testosterone or androstenedione, and steroid hormone clearance was measured by mass spectrometry. Glucocorticoid and androgen receptor activation were determined by luciferase reporter assays. AKR1D1-002 and AKR1D1-001 are expressed in human liver, and only AKR1D1-006 is expressed in human testes. Following overexpression, AKR1D1-001 and AKR1D1-006 protein levels were lower than AKR1D1-002, but significantly increased following treatment with the proteasomal inhibitor, MG-132. AKR1D1-002 efficiently metabolised glucocorticoids and androgens and decreased receptor activation. AKR1D1-001 and AKR1D1-006 poorly metabolised dexamethasone, but neither protein metabolised cortisol, prednisolone, testosterone or androstenedione. We have demonstrated the differential expression and role of AKR1D1 variants in steroid hormone clearance and receptor activation in vitro. AKR1D1-002 is the predominant functional protein in steroidogenic and metabolic tissues. In addition, AKR1D1-001 and AKR1D1-006 may have a limited, steroid-specific role in the regulation of dexamethasone action. |
format | Online Article Text |
id | pubmed-7965358 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Bioscientifica Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-79653582021-03-24 Differential activity and expression of human 5β-reductase (AKR1D1) splice variants Appanna, Nathan Gibson, Hylton Gangitano, Elena Dempster, Niall J Morris, Karen George, Sherly Arvaniti, Anastasia Gathercole, Laura L Keevil, Brian Penning, Trevor M Storbeck, Karl-Heinz Tomlinson, Jeremy W Nikolaou, Nikolaos J Mol Endocrinol Research Steroid hormones, including glucocorticoids and androgens, exert a wide variety of effects in the body across almost all tissues. The steroid A-ring 5β-reductase (AKR1D1) is expressed in human liver and testes, and three splice variants have been identified (AKR1D1-001, AKR1D1-002, AKR1D1-006). Amongst these, AKR1D1-002 is the best described; it modulates steroid hormone availability and catalyses an important step in bile acid biosynthesis. However, specific activity and expression of AKR1D1-001 and AKR1D1-006 are unknown. Expression of AKR1D1 variants were measured in human liver biopsies and hepatoma cell lines by qPCR. Their three-dimensional (3D) structures were predicted using in silico approaches. AKR1D1 variants were overexpressed in HEK293 cells, and successful overexpression confirmed by qPCR and Western blotting. Cells were treated with either cortisol, dexamethasone, prednisolone, testosterone or androstenedione, and steroid hormone clearance was measured by mass spectrometry. Glucocorticoid and androgen receptor activation were determined by luciferase reporter assays. AKR1D1-002 and AKR1D1-001 are expressed in human liver, and only AKR1D1-006 is expressed in human testes. Following overexpression, AKR1D1-001 and AKR1D1-006 protein levels were lower than AKR1D1-002, but significantly increased following treatment with the proteasomal inhibitor, MG-132. AKR1D1-002 efficiently metabolised glucocorticoids and androgens and decreased receptor activation. AKR1D1-001 and AKR1D1-006 poorly metabolised dexamethasone, but neither protein metabolised cortisol, prednisolone, testosterone or androstenedione. We have demonstrated the differential expression and role of AKR1D1 variants in steroid hormone clearance and receptor activation in vitro. AKR1D1-002 is the predominant functional protein in steroidogenic and metabolic tissues. In addition, AKR1D1-001 and AKR1D1-006 may have a limited, steroid-specific role in the regulation of dexamethasone action. Bioscientifica Ltd 2021-01-12 /pmc/articles/PMC7965358/ /pubmed/33502336 http://dx.doi.org/10.1530/JME-20-0160 Text en © 2021 The authors http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Appanna, Nathan Gibson, Hylton Gangitano, Elena Dempster, Niall J Morris, Karen George, Sherly Arvaniti, Anastasia Gathercole, Laura L Keevil, Brian Penning, Trevor M Storbeck, Karl-Heinz Tomlinson, Jeremy W Nikolaou, Nikolaos Differential activity and expression of human 5β-reductase (AKR1D1) splice variants |
title | Differential activity and expression of human 5β-reductase (AKR1D1) splice variants |
title_full | Differential activity and expression of human 5β-reductase (AKR1D1) splice variants |
title_fullStr | Differential activity and expression of human 5β-reductase (AKR1D1) splice variants |
title_full_unstemmed | Differential activity and expression of human 5β-reductase (AKR1D1) splice variants |
title_short | Differential activity and expression of human 5β-reductase (AKR1D1) splice variants |
title_sort | differential activity and expression of human 5β-reductase (akr1d1) splice variants |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7965358/ https://www.ncbi.nlm.nih.gov/pubmed/33502336 http://dx.doi.org/10.1530/JME-20-0160 |
work_keys_str_mv | AT appannanathan differentialactivityandexpressionofhuman5breductaseakr1d1splicevariants AT gibsonhylton differentialactivityandexpressionofhuman5breductaseakr1d1splicevariants AT gangitanoelena differentialactivityandexpressionofhuman5breductaseakr1d1splicevariants AT dempsterniallj differentialactivityandexpressionofhuman5breductaseakr1d1splicevariants AT morriskaren differentialactivityandexpressionofhuman5breductaseakr1d1splicevariants AT georgesherly differentialactivityandexpressionofhuman5breductaseakr1d1splicevariants AT arvanitianastasia differentialactivityandexpressionofhuman5breductaseakr1d1splicevariants AT gathercolelaural differentialactivityandexpressionofhuman5breductaseakr1d1splicevariants AT keevilbrian differentialactivityandexpressionofhuman5breductaseakr1d1splicevariants AT penningtrevorm differentialactivityandexpressionofhuman5breductaseakr1d1splicevariants AT storbeckkarlheinz differentialactivityandexpressionofhuman5breductaseakr1d1splicevariants AT tomlinsonjeremyw differentialactivityandexpressionofhuman5breductaseakr1d1splicevariants AT nikolaounikolaos differentialactivityandexpressionofhuman5breductaseakr1d1splicevariants |